163 related articles for article (PubMed ID: 17804550)
1. Cancer immunomics: from serological proteome analysis to multiple affinity protein profiling.
Hardouin J; Lasserre JP; Sylvius L; Joubert-Caron R; Caron M
Ann N Y Acad Sci; 2007 Jun; 1107():223-30. PubMed ID: 17804550
[TBL] [Abstract][Full Text] [Related]
2. Identifying autoantibody signatures in cancer: a promising challenge.
Desmetz C; Maudelonde T; Mangé A; Solassol J
Expert Rev Proteomics; 2009 Aug; 6(4):377-86. PubMed ID: 19681673
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
4. A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers.
Grandjean M; Dieu M; Raes M; Feron O
J Immunol Methods; 2013 Oct; 396(1-2):23-32. PubMed ID: 23916966
[TBL] [Abstract][Full Text] [Related]
5. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K
Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718
[TBL] [Abstract][Full Text] [Related]
6. A proteomic approach based on multiple parallel separation for the unambiguous identification of an antibody cognate antigen.
Mun J; Kim YH; Yu J; Bae J; Noh DY; Yu MH; Lee C
Electrophoresis; 2010 Oct; 31(20):3428-36. PubMed ID: 20872419
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunomics using autoantibody signatures for biomarker discovery.
Caron M; Choquet-Kastylevsky G; Joubert-Caron R
Mol Cell Proteomics; 2007 Jul; 6(7):1115-22. PubMed ID: 17376768
[TBL] [Abstract][Full Text] [Related]
8. Serological immunoreactivity against colon cancer proteome varies upon disease progression.
De Monte L; Sanvito F; Olivieri S; Viganò F; Doglioni C; Frasson M; Braga M; Bachi A; Dellabona P; Protti MP; Alessio M
J Proteome Res; 2008 Feb; 7(2):504-14. PubMed ID: 18179166
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody profiles as biomarkers of breast cancer.
Tabernero MD; Lv LL; Anderson KS
Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
[TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma.
Tong YQ; Zhang ZJ; Liu B; Huang J; Liu H; Liu Y; Guo FJ; Zhou GH; Xie PL; Li YH; Zuo CH; Hu JY; Li GC
Proteomics; 2008 Aug; 8(15):3185-93. PubMed ID: 18654982
[TBL] [Abstract][Full Text] [Related]
13. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
Fernández Madrid F
Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
[TBL] [Abstract][Full Text] [Related]
16. [Screening human gastric carcinoma-associated antigens by serologic proteome analysis].
Zeng X; Liao AJ; Tang HL; Yi L; Xie N; Su Q
Ai Zheng; 2007 Oct; 26(10):1080-4. PubMed ID: 17927877
[TBL] [Abstract][Full Text] [Related]
17. [Proteome analysis of autoantibodies in sera of patients with cancer].
Ueda K
Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
19. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
Wimmer H; Gundacker NC; Griss J; Haudek VJ; Stättner S; Mohr T; Zwickl H; Paulitschke V; Baron DM; Trittner W; Kubicek M; Bayer E; Slany A; Gerner C
Electrophoresis; 2009 Jun; 30(12):2076-89. PubMed ID: 19582709
[TBL] [Abstract][Full Text] [Related]
20. A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins.
Canelle L; Bousquet J; Pionneau C; Hardouin J; Choquet-Kastylevsky G; Joubert-Caron R; Caron M
Electrophoresis; 2006 Apr; 27(8):1609-16. PubMed ID: 16550497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
